Arkade Developers acquires new redevelopment project in Goregaon West with Rs 350 crore revenue potential
Arkade Developers Limited has acquired redevelopment rights for a key residential society in Bangur Nagar, Goregaon West, Mumbai. The 1.1-acre site offers a RERA saleable area of approximately 86,000 sq. ft. and an estimated revenue potential of ₹350 crore.
The project will feature a mix of residential and commercial spaces, reinforcing Arkade's presence in the fast-growing Goregaon-Malad micro-market. This marks the company's fifth acquisition in this belt, where it already has four completed and three ongoing projects.
Designed to offer a blend of 2 and 3 BHK thoughtfully planned homes, the new development is strategically located with excellent road, rail, and metro connectivity, along with access to robust social infrastructure.
Amit Jain, Chairman and Managing Director, Arkade Developers Limited, commented, 'Our foray into yet another society redevelopment project in Goregaon reaffirms Arkade's strong and growing footprint in this vital Mumbai suburb. We understand Goregaon's unique pulse and potential, having successfully delivered transformative projects in the area in the past. This latest acquisition aligns with our vision to create vibrant, future-ready spaces that add enduring value for homeowners, commercial users and the wider community.'
This acquisition aligns with Arkade's continued focus on high-potential redevelopment opportunities in Mumbai's Western suburbs. The company aims to deliver modern living spaces that reflect its commitment to quality, design, and sustainable urban living.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Kamat Hotels signs second North Goa property under IRA by Orchid brand
By Aman Shukla Published on August 19, 2025, 12:08 IST Kamat Hotels (India) Limited (KHIL), a pioneer in eco-friendly hospitality, has announced the signing of its second property in North Goa under the 'IRA by Orchid' brand. The new hotel, set to open by September 30, 2025, will further strengthen KHIL's presence in one of India's most loved travel destinations. The upcoming IRA by Orchid Hotel – North Goa will feature 43 stylish guest rooms, a swimming pool, banquet hall, all-day dining restaurant, and a modern health club. With its signature Orchid hospitality, the property aims to offer guests a perfect mix of leisure, comfort, and convenience. North Goa continues to be a favorite spot for both Indian and international tourists, known for its lively beaches, Portuguese heritage, vibrant markets like Anjuna and Mapusa, and serene stretches such as Vagator and Morjim. By adding this property, KHIL looks to cater not only to leisure travelers but also to event guests seeking premium hospitality in Goa. Vithal Kamat, Executive Chairman & Managing Director, stated, 'We are delighted to announce our new hotel in North Goa, a destination that holds immense potential for hospitality and tourism. This will be another milestone in our growth journey under the IRA by Orchid brand, and we remain committed to offering eco-friendly, world-class hospitality experiences to our guests across India.' Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
3 hours ago
- Business Upturn
Tembo Global bags EPC contract worth USD 12.44 million at Colombo Airport
Tembo Global Industries Limited has announced that it has won a major international Engineering, Procurement, and Construction (EPC) contract worth USD 12.44 million for the construction of Aviation Turbine Fuel (ATF) storage tanks at Bandaranaike International Airport, Colombo, Sri Lanka. The scope of the project includes complete design, engineering, procurement, construction, and commissioning of ATF storage tanks along with associated piping, electrical, and instrumentation systems. This project is seen as a significant milestone for Tembo Global Industries as it strengthens the company's footprint in the international EPC market and is expected to boost its revenues and business growth. The project highlights Tembo's growing presence in the global infrastructure and energy sector. The company confirmed that the order has been awarded by an international entity and does not fall under related party transactions. With this contract, Tembo Global Industries positions itself strongly in specialized infrastructure development, particularly in aviation fuel storage and distribution systems. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
4 hours ago
- Business Upturn
Glenmark Pharma to launch Micafungin for Injection USP in the US market
By Aman Shukla Published on August 19, 2025, 09:52 IST Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the upcoming launch of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial). The product is bioequivalent and therapeutically equivalent to the reference listed drug Mycamine® for Injection by Astellas Pharma US, Inc. (NDA – 021506). The company confirmed that distribution will begin in September 2025. According to IQVIA sales data for the 12-month period ending June 2025, the Mycamine® for Injection market (50 mg/vial and 100 mg/vial) generated approximately $60.7 million in annual sales. Glenmark aims to capture a share of this market by offering a high-quality and more affordable alternative. Commenting on the launch, Marc Kikuchi, President & Business Head, North America, said, 'We are excited to introduce Micafungin for Injection USP, further strengthening our institutional product portfolio and reinforcing our commitment to deliver accessible, affordable, and quality medicines to patients in need.' The new launch is expected to expand Glenmark's presence in the U.S. injectable market while enhancing treatment options for patients. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
